Volume 22, Issue 4 - Good Pharma

Providing value for medicines in older people

Author: Barbro Westerholm

Abstract

Download the full article

References

1. United Nations Department of Economic and Social Affairs Population Division. World Population Ageing 1950–2050. ST/ESA/SER.A/207. New York, 2001.
2. Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. Consortium for the European Review of Social Determinants of Health and the Health Divide. Lancet. 2012;380(9846):1011–29.
3. Swedish National Board of Health and Welfare. Drug treatment in elderly care. Report from national thematic supervision of activities. Stockholm: Swedish National Board of Health and Welfare; 2004. Swedish.
4. Larkin M. Robert Butler: championing a healthy view of ageing. Lancet. 2001;357(9249):48.
5. Commission of the European Communities. Proposal for a Council Directive on implementing the principle of equal treatment between persons irrespective of religion or belief, disability, age or sexual orientation. Brussels: Commission of the European Communities; 2008. COM(2008)426 final.
6. Council of the European Union. Regulation (EC) No 1901/2006 of the European parliament and of the Council of 12 December 2006 on medicinal products for paediatric use. Off J Eur Union 2006;L 378/1.
7. European Medicines Agency. EMA geriatric medicines strategy. EMA/CHMP/137793/2011. London: Council of the European Union; 2011. EMA/CHMP/137793/2011.
8. Boëthius G, Westerholm B. How much can we determine about consumption of psychotropic drugs? Läkartidningen 1979;76(46):4101–4102. Swedish.
9. de Almeida A, Aslani P. Medicines concordance in clinical practice. Br J Clin Pharmacol 2008;66(4):453–454.
10. Swedish National Board of Health and Welfare. Public comparisons 2013: drug treatments. Stockholm: Swedish National Board of Health and Welfare; 2013. Swedish.
11. Swedish National Board of Health and Welfare. Indications for good drug treatment in older persons. Stockholm: Swedish National Board of Health and Welfare; 2010. Swedish.
12. O'Mahony D. Medication errors: older patients & their caregivers. Presentation at the European Union Regulatory Workshop on Medication Errors; London; 28 February–1 March 2013 [cited 2013 September 11]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2013/03/WC500139866.pdf
13. European Medicines Agency. Tackling medication errors: European Medicines Agency workshop calls for coordinated EU approach [press release]. London: European Medicines Agency; 2013.
14. Council of the European Union. Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance. Directive 2001/83/EC on the Community code relating to medicinal products for human use. Off J Eur Union 2010;L348/84.